Bioanalytical

Bioanalysis of Dermorphin, an Opioid Peptide in Equine Urine: Benefit of the VIP-Heated ESI Technology for the Quantitative Analysis of Thermally Labile Molecules

Author: Maurizio Splendore, Chris Kellogg and Rohan Thakur on behalf of Unassigned Independent Article

Free to read

This article has been unlocked and is ready to read.

Download

Dermorphin is an opioid hepta-peptide derived from the skin secretions of South American frogs (Phyllomedusa sauvagei)1. It is 30-to-40 times more potent an analgesic than morphine2 and is unique because it contains D-alanine, a property that makes it highly resistant to protease mediated degradation (Figure 1). While d-amino acid peptides are sought after for their low immunogenic response and in peptidomimetic drug design, it was dermorphin’s use in horse racing that catapulted this opioid peptide from obscurity into the headlines. The pain-killing properties of dermorphin were used to drive racehorse performance beyond normal physical limits often injuring the animal. As a result, dermorphin is now a Class I prohibited substance as decreed by the Association of Racing Commissioners International (RCI) Model Rules3.
 

Free to read

This article has been unlocked and is ready to read.

Download


Events

PITTCON 2025

Mar 01 2025 Boston, MA, USA

H2 Forum

Mar 04 2025 Berlin, Germany

NGVS 2025

Mar 18 2025 Beijing, China

Forum Labo Paris

Mar 25 2025 Paris, France

CISILE 2025

Mar 31 2025 Beijing, China

View all events

Redirecting you now.
Labmate Awards Nominations - Open
The Labmate Awards for Excellence 2025 seek to recognise innovation, quality and achievement wherever it occurs within the laboratory sector. Launching this year the Labmate Awards for Excellence 2025 will have eleven voting categories chosen to reflect the broad range of noteworthy contributions that have been made across our industry in the past 12 months. Nominate your company Now.